Polymorphonuclear granulocyte stimulation by cellulose-based hemodialysis membranes

Clinical Chemistry and Laboratory Medicine

Volumn 37, Issue 3, 1999, Pages 351-355

  Körmöczi, Günther F ^a   Rosenkranz, Alexander R ^b   Zlabinger, Gerhard J ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Adhesion molecules; Cellulose based membranes; Complement; Granulocyte; Hemodialysis; Oxidative burst

Indexed keywords

CELLULOSE; REACTIVE OXYGEN METABOLITE;

CELL STIMULATION; COMPLEMENT ACTIVATION; CONFERENCE PAPER; DIALYSIS MEMBRANE; HUMAN; HYPOXEMIA; INFLAMMATION; LEUKOCYTE DISORDER; LEUKOPENIA; LUNG DISEASE; LUNG SEQUESTRATION; NEUTROPENIA; NEUTROPHIL; NEUTROPHILIA; PLASMA; PRIORITY JOURNAL; RESPIRATORY BURST;

ANTIGENS, CD11; ANTIGENS, CD18; CELLULOSE; HUMANS; MEMBRANES, ARTIFICIAL; NEUTROPHILS; RENAL DIALYSIS;

EID: 17344378925     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1999.058     Document Type: Conference Paper

References (60)

1. Schiffl H, Lang SM, König A, Strasser T, Haider MC, Held E. Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet 1994; 344:570-2.
2. Lazarus JM, Owen W F. Role of bioincompatibility in dialysis morbidity and mortality. Am J Kidney Dis 1994; 24:1019-32.
3. Cheung AK, Leypoldt JK. The hemodialysis membranes: a historical perspective, current state and future prospect. Semin Nephrol 1997; 17:196-213.
4. Hoenich NA, Woffindin C, Stamp S, Roberts SJ, Turnbull J. Synthetically modified cellulose: an alternative to synthetic membranes for use in hemodialysis? Biomaterials 1997; 18:1299-303.
5. Daugirdas JD, Ing TS. First-use reactions during hemodialysis: a definition of subtypes. Kidney Int 1988; 33: Suppl 24:S37-S43.
6. Levin NW, Zasuwa G. Relationship between dialyser type and signs and symptoms. Nephrol Dial Transplant 1993; 8: Suppl 2:30-9.
7. Kaplow LS, Goffinet JA. Profound neutropenia during the early phase of hemodialysis. J Am Med Assoc 1968; 203:1134-47.
8. Craddock PR, Hammerschmidt DE, White JG, Dalmasso AP, Jacob HS. Complement (C5a)-induced granulocyte aggregation in vitro: a possible mechanism of complementmediated leukostasis and leukopenia. J Clin Invest 1977; 60:260-4.
9. Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 1977; 296:769-74.
10. Craddock PR, Fehr J, Dalmasso AP, Brigham KL, Jacob HS. Hemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyser cellophane membrane. J Clin Invest 1977; 59:879-88.
11. Hakim RM, Breilatt J, Lazarus JM, Port FK. Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 1984; 311:878-82.
12. Hakim RM, Lowrie EG. Hemodialysis-associated neutropenia and hypoxemia: the effect of dialyzer membrane materials. Nephron 1982; 32:32-9.
13. Raasveld, MHM, Bemelman FJ, Schellekens PTA, van Diepen FNJ, van Dongen A, van Royen EA, et al. Complement activation during OKT3 treatment: a possible explanation for respiratory side effects. Kidney Int 1993; 43:1140-9.
14. Robbins RA, Russ WD, Rasmussen JK, Clayton MM. Activation of the complement system in the adult respiratory distress syndrome. Am Rev Respir Dis 1987; 135:651-8.
15. Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardio-thorac Surg 1993; 7:563-73.
16. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84:2068-101.
17. Crockett-Torabi E. Selectins and mechanisms of signal transduction. J Leukoc Biol 1998; 63:1-14.
18. Sengelov H. Complement receptors in neutrophils. Crit Rev Immunol 1995; 15:107-31.
19. Simon, SI, Rochon YP, Lynam EB, Smith CW, Anderson DC, Sklar LA. ß2-Integrin and L-selectin are obligatory receptors in neutrophil aggregation. Blood 1993; 82:1097-106.
20. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997; 89:3503-21.
21. Crockett-Torabi E, Sulenbarger B, Smith CW, Fantone JC. Activation of human neutrophils through L-selectin and Mac-1 molecules. J Immunol 1995; 154:2291-302.
22. Steeber DA, Engel P, Miller AS, Sheetz MP, Tedder TF. Ligation of L-selectin through conserved regions within the lectin domain activates signal transduction pathways and integrin function in human, mouse, and rat leukocytes. J Immunol 1997; 159:952-63.
23. Newton RA, Thiel M, Hogg N. Signaling mechanisms and the activation of leukocyte integrins. J Leukoc Biol 1997; 61:422-6.
24. Kuijpers TW, Tool ATJ, van der School CE, Ginsel LA, Onderwater JJM, Roos D, et al. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 1991; 78:1105-11.
25. Muller WA. The role of PECAM-1 (CD31) in leukocyte emigration: studies in vitro and in vivo. J Leukoc Biol 1995; 57:523-8.
26. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320:365-76.
27. Lee J, Hakim RM, Fearon DT. Increased expression of the C3b receptor by neutrophils and complement activation during hemodialysis. Clin Exp Immunol 1984; 56:205-14.
28. Arnaout MA, Hakim RM, Todd RF, Dana N, Colten HR. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med 1985; 312:457-62.
29. Himmelfarb J, Zaoui P, Holbrook D, Hakim R. Modulation of granulocyte LAM-1 and Mac-1 during dialysis - a prospective, randomized controlled trial. Kidney Int 1992; 41:388-98.
30. Lundahl J, Hed J, Jacobson SH. Dialysis granulocytopenia is preceded by an increased surface expression of the adhesion-promoting glycoprotein Mac-1. Nephron 1992; 61:163-9.
31. Alvarez V, Pulido R, Campanero MR, Paraiso V, De Landozuri MO, Sanchez-Madrid F. Differentially regulated cell surface expression of leukocyte adhesion receptors on neutrophils. Kidney Int 1991; 40:899-905.
32. Rosenkranz AR, Körmöczi GF, Thalhammer F, Menzel EJ, Hörl WH, Mayer G, et al. Novel 05-dependent mechanism of neutrophil stimulation by bioincompatible dialyzer membranes. J Am Soc Nephrol 1999; 10:128-35.
33. Combe C, Fountain M, de Precigout V, Baquey A, Morel D, Potaux L, et al. Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane. Am J Kidney Dis 1994; 24:437-42.
34. Mulligan MS, Smith CW, Anderson DC, Todd RF III, Miyasaka M, Tamatani T, et al. Role of leukocyte adhesion molecules in complement-induced lung injury. J Immunol 1993; 150:2401-6.
35. Kolb G, Fischer W, Schoenemann H, Bathke K, Hoffken H, Muller T, et al. Effect of cuprophan, hemophan and polysulfone membrans on the oxidative metabolism, degranulation reaction, enzyme release and pulmonary sequestration of granulocytes. Contrib Nephrol 1989; 74:10-21.
36. Kjellstrand P, Jacobson SH, Skröder R, Holmquist B, Boberg U, Lins LE, et al. Leukocyte overshoot: a new sign of bioincompatibility in fast hemodialysis. ASAIO Trans 1990; 36:M314-M6.
37. Rabb H, Agosti SJ, Bittle PA, Fernandez M, Ramirez G, Tedder TF. Alterations in soluble and leukocyte surface L-selectin (CD62L) in hemodialysis patients. J Am Soc Nephrol 1995; 6:1445-50.
38. Kuypers TW, Koenderman L, Weening RS, Verhoeven AJ, Roos D. Continuous cell activation is necessary for stable interaction of complement receptor type 3 with its counter-structure in the aggregation response of human neutrophils. Eur J Immunol 1990; 20:501-8.
39. Rosenkranz AR, Majdic O, Stöckl J, Pickl W, Stockinger H, Knapp W. Induction of neutrophil homotypic adhesion via sialophorin (CD43), a surface sialoglycoprotein restricted to haemopoietic cells. Immunology 1993; 80:431-8.
40. Skubitz KM, Campbell KD, Skubitz APN. CD66a, CD66b, CD66c, and CD66d each independently stimulate neutrophils. J Leukoc Biol 1996; 60:106-17.
41. Vanholder R, Ringoir S, Dhondt A, Hakim R. Phagocytosis in uremic and hemodialysis patients: a prospective and cross-sectional study. Kidney Int 1991; 39:320-7.
42. Himmelfarb, Lazarus JM, Hakim R. Reactive oxygen species production by monocytes and polymorphnuclear leukocytes during dialysis. Am J Kidney Dis 1991; 17:271-6.
43. Cheung AK, Parker CJ, Wilcox L, Janatova J. Activation of the alternative pathway of complement by cellulosic hemodialysis membranes. Kidney Int 1989; 36:257-65.
44. Lhotta K, Würzner R, Kronenberg F, Oppermann M, König P. Rapid activation of the complement system by cuprophane depends on complement component C4. Kidney Int 1998; 53:1044-51.
45. Cheung AK, Hohnholt M, Gilson J. Adherence of neutrophils to hemodialysis membranes: role of complement receptors. Kidney Int 1991; 40:1123-33.
46. Cheung AK, Parker CJ, Hohnholt M. Soluble complement receptor type 1 inhibits complement activation induced by hemodialysis membranes in vitro. Kidney Int 1994; 46: 1680-7.
47. 2-Integrins are required for neutrophil degranulation induced by hemodialysis membranes. Kidney Int 1993; 43:649-60.
48. Böhler J, Schollmeyer P, Dressel B, Dobos G, Hörl WH. Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation. J Am Soc Nephrol 1996; 7:234-41.
49. Rosenkranz AR, Tempi E, Traindl O, Heinzl H, Zlabinger GJ. Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranes. Clin Exp Immunol 1994; 98:300-5.
50. Hakim RM, Fearon DT, Perzanowski CS, Lazarus JM. Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int 1984; 26:194-200.
51. Foreman KE, Glovsky MM, Warner RL, Horvath SJ, Ward PA. Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells. Inflammation 1996; 20:1-9.
52. Niculescu, F, Rus H, Shin ML. Receptor-independent activation of guanine nucleotide-binding regulatory proteins by terminal complement complexes. J Biol Chem 1994; 269:4417-23.
53. Seeger W, Suttorp N, Hellwig A, Bhakdi S. Noncytolytic terminal complement complexes may serve as calcium gate to elicit leukotriene B4 generation in human polymorphonuclear leukocytes. J Immunol 1986; 137:1286-93.
54. Wang C, Gerard NP, Nicholson-Weller A. Signaling by hemolytically inactive C5b67, an agonist of polymorphonuclear leukocytes. J Immunol 1996; 156:786-92.
55. Czermak BJ, Lentsch AB, Bless NM, Schmal H, Friedl HP, Ward PA. Role of complement in in vitro and in vivo lung inflammatory reactions. J Leukoc Biol 1998; 64:40-8.
56. Descamps-Latscha B, Goldfarb B, Nguyen AT, Landais P, London G, Haeffner-Cavaillon, et al. Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism, in hemodialyzed patients: a randomized prospective study. Nephron 1991; 59:279-85.
57. Himmelfarb J, McMonagle E, Holbrook D, Toth C. Soluble complement receptor 1 inhibits both complement and granulocyte activation during ex vivo hemodialysis. J Lab Clin Med 1995; 126:392-400.
58. Haensch GM, Karnaoukhova S, Chang SH, Rus H, Nicolescu F, Deppisch R, et al. Activation of human neutrophils after contact with cellulose-based haemodialysis membranes; intracellular calcium signalling in single cells. Nephrol Dial Transplant 1996;11:2453-60.
59. Fraticelli A, Serrano CV Jr, Bochner BS, Capogrossi MC, Zweier JL. Hydrogen peroxide and Superoxide modulate leukocyte adhesion molecule expression and leukocyte endothelial adhesion. Biochim Biophys Acta 1996; 1310:251-9.
60. Vogt W. Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes, Immunobiology 1996; 195:334-46.